When infection attacks the body, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic; including antitubercular), antiviral, antifungal and antiparasitic (including antiprotozoal and antihelminthic) agents. Scope of the Report: This report studies the Infectious Disease Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Infectious Disease Treatment market by product type and applications/end industries. Depending on the severity and the type of infection, the antibiotic may be given by mouth or by injection, or may be applied topically. Severe infections of the brain are usually treated with intravenous antibiotics. Sometimes, multiple antibiotics are used in case there is resistance to one antibiotic. The global Infectious Disease Treatment market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023. The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions. North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Infectious Disease Treatment. Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%. Market Segment by Companies, this report covers Pfizer F.Hoffman-La Roche Abbott Laboratories Abbvie Merck & Company Alere Allergan Bayer Baxter International Bristol-Myers Squibb Actelion Pharmaceuticals Gilead Sciences Market Segment by Regions, regional analysis covers North America (United States, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia-Pacific (China, Japan, Korea, India and Southeast Asia) South America (Brazil, Argentina, Colombia) Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Market Segment by Type, covers Antibacterial drugs Antiviral drugs Antifungal drugs Antiparasitic drugs Market Segment by Applications, can be divided into Acquired Immune Deficiency Syndrome Hepatitis B Hepatitis C Human Papillomavirus Hospital acquired Methicillin-resistant Staphylococcus aureus infection Chlamydia trachomatis and Neisseria Gonorrhea
Table of Contents 1 Infectious Disease Treatment Market Overview 1.1 Product Overview and Scope of Infectious Disease Treatment 1.2 Classification of Infectious Disease Treatment by Types 1.2.1 Global Infectious Disease Treatment Revenue Comparison by Types (2017-2023) 1.2.2 Global Infectious Disease Treatment Revenue Market Share by Types in 2017 1.2.3 Anti
